General MedicationsFOR RX COMPOUNDINGGeneric
ERYTHROMYCIN
ERYTHROMYCIN
Standard Dose
100%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview ERYTHROMYCIN is listed in Drugs@FDA under application 050610 (NDA).
Marketing status: Discontinued Active ingredient ERYTHROMYCIN Form and strength POWDER;FOR RX COMPOUNDING - 100% Sponsor PADDOCK LLC Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview ERYTHROMYCIN is listed in Drugs@FDA under application 050610 (NDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN Form and strength POWDER;FOR RX COMPOUNDING - 100% Sponsor PADDOCK LLC Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.